Additionally, the degradation of p105 not only generates p50 but also releases the associated MAPK kinase TPL-2 (tumor progression locus-2), enabling it to activate the ERK/MAPK cascade, another pathway involved in promoting inflammatory responses (Beinke and Ley, 2004). Here, NFKB1 is linked to neoplasm.